Sample result

GLP-1, a diabetes hormone

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

The search

Query: GLP-1 · 31 lettersHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
From: UniProt P01275, residues 98 to 128
Search: Protein → Patent proteins · Automatic (Smith-Waterman)
Set: Public patent sequences: Patent proteins, snapshot 2026-11-05-c456f6bdba29
Ran: 2026-11-12
Found: 5,000 sequences, 3,061 publications, 1,851 families

Smith-Waterman compares each query with every stored sequence. Each query returns up to 5,000 sequences, with the best alignment of each. FASTA36 fits its E-values to a random sample of scores, so a sequence near the cutoff can come and go between runs. These results do not establish patentability.

Patents

3,061 publications in 1,851 families match these filters.

KR 1020220021890-A2022-02-22

PHARMACEUTICAL COMPOSITION COMPRISING LONG-ACTING CONJUGATE OF TRIPLE GLUCAGON/GLP-1/GIP RECEPTOR AGONIST

HANMI PHARM. CO., LTD

Query Match 87.0%Identity 89.7%Family of 2
Best alignment and family
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         |  ||||||||||| ||||||||||||||
Hit    1 HXQGTFTSDVSSYLDGQAAKEFIAWLVKG 29
```
26 of 29 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020220021890-A2022-02-22
- JP 2023537895-A2023-09-06
KR 1020220021895-A2022-02-22

A composition comprising a trigonal glucagon/GLP-1/GIP receptor agonist for lowering blood pressure

HANMI PHARM. CO., LTD

Query Match 87.0%Identity 89.7%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         |  ||||||||||| ||||||||||||||
Hit    1 HXQGTFTSDVSSYLDGQAAKEFIAWLVKG 29
```
26 of 29 identical, no gaps.
KR 1020220041764-A2022-04-01

A pharmaceutical composition for preventing or treating neurodegenerative disease, comprising Trigonal glucagon/GLP-1/GIP receptor agonist or a conjugate thereof

HANMI PHARM. CO., LTD

Query Match 87.0%Identity 89.7%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         |  ||||||||||| ||||||||||||||
Hit    1 HXQGTFTSDVSSYLDGQAAKEFIAWLVKG 29
```
26 of 29 identical, no gaps.
KR 1020220041765-A2022-04-01

A pharmaceutical composition for preventing or treating bone disorders, comprising Trigonal glucagon/GLP-1/GIP receptor agonist or a conjugate thereof

HANMI PHARM. CO., LTD

Query Match 87.0%Identity 89.7%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         |  ||||||||||| ||||||||||||||
Hit    1 HXQGTFTSDVSSYLDGQAAKEFIAWLVKG 29
```
26 of 29 identical, no gaps.
KR 1020220041766-A2022-04-01

Long acting conjugate of Trigonal glucagon/GLP-1/GIP receptor agonist for use in the treatment of multiple sclerosis

HANMI PHARM. CO., LTD

Query Match 87.0%Identity 89.7%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         |  ||||||||||| ||||||||||||||
Hit    1 HXQGTFTSDVSSYLDGQAAKEFIAWLVKG 29
```
26 of 29 identical, no gaps.
KR 1020220050821-A2022-04-25

Pharmaceutical composition for preventing or treating vasculitis comprising glucagon/GLP-1/GIP triple agonist or long acting conjugate thereof

HANMI PHARM. CO., LTD

Query Match 87.0%Identity 89.7%Family of 2
Best alignment and family
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         |  ||||||||||| ||||||||||||||
Hit    1 HXQGTFTSDVSSYLDGQAAKEFIAWLVKG 29
```
26 of 29 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020220050821-A2022-04-25
- JP 2023546085-A2023-11-01
KR 1020220050822-A2022-04-25

Pharmaceutical composition for preventing or treating lupus-associated diseases comprising glucagon/GLP-1/GIP triple agonist or long acting conjugate thereof

HANMI PHARM. CO., LTD

Query Match 87.0%Identity 89.7%Family of 2
Best alignment and family
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         |  ||||||||||| ||||||||||||||
Hit    1 HXQGTFTSDVSSYLDGQAAKEFIAWLVKG 29
```
26 of 29 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020220050822-A2022-04-25
- JP 2023546088-A2023-11-01
KR 1020220050824-A2022-04-25

Trigonal glucagon/GLP-1/GIP receptor agonist for use in the treatment of sequelae of respiratory infection

HANMI PHARM. CO., LTD

Query Match 87.0%Identity 89.7%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         |  ||||||||||| ||||||||||||||
Hit    1 HXQGTFTSDVSSYLDGQAAKEFIAWLVKG 29
```
26 of 29 identical, no gaps.
KR 1020230004135-A2023-01-06

Therapeutic use of a combination comprising a trigonal glucagon/GLP-1/GIP receptor agonist

HANMI PHARM. CO., LTD

Query Match 87.0%Identity 89.7%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         |  ||||||||||| ||||||||||||||
Hit    1 HXQGTFTSDVSSYLDGQAAKEFIAWLVKG 29
```
26 of 29 identical, no gaps.
US 11603346-B22023-03-14

Polyethylene glycol derivative and use thereof

HANMI PHARM. CO., LTD.

Query Match 87.0%Identity 89.7%Family of 2
Best alignment and family
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         |  ||||||||||| ||||||||||||||
Hit    1 HXQGTFTSDVSSYLDGQAAKEFIAWLVKG 29
```
26 of 29 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- US 11603346-B22023-03-14
- US 12139455-B22024-11-12
KR 1020230095665-A2023-06-29

Hepatic targeting drug and use thereof

HANMI PHARM. CO., LTD

Query Match 87.0%Identity 89.7%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         |  ||||||||||| ||||||||||||||
Hit    1 HXQGTFTSDVSSYLDGQAAKEFIAWLVKG 29
```
26 of 29 identical, no gaps.
JP 2023535382-A2023-08-17

Therapeutic use of combination comprising triple agonistic long-acting conjugate or triple agonist

HANMI PHARM CO LTD

Query Match 87.0%Identity 89.7%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         |  ||||||||||| ||||||||||||||
Hit    1 HXQGTFTSDVSSYLDGQAAKEFIAWLVKG 29
```
26 of 29 identical, no gaps.
JP 2023538236-A2023-09-07

HYPOTENSIVE PHARMACEUTICAL COMPOSITION COMPRISING TRIPLE ACTIVATOR HAVING ACTIVITY FOR ALL OF GLUCAGON, GLP-1, AND GIP RECEPTORS

HANMI PHARM CO LTD

Query Match 87.0%Identity 89.7%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         |  ||||||||||| ||||||||||||||
Hit    1 HXQGTFTSDVSSYLDGQAAKEFIAWLVKG 29
```
26 of 29 identical, no gaps.
JP 2023543036-A2023-10-12

THERAPEUTIC USE, FOR NEURODEGENERATIVE DISEASES, OF TRIPLE AGONIST HAVING ACTIVITY WITH RESPECT TO ALL OF GLUCAGON, GLP-1, AND GIP RECEPTORS, OR CONJUGATE THEREOF

HANMI PHARM CO LTD

Query Match 87.0%Identity 89.7%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         |  ||||||||||| ||||||||||||||
Hit    1 HXQGTFTSDVSSYLDGQAAKEFIAWLVKG 29
```
26 of 29 identical, no gaps.
JP 2023543042-A2023-10-12

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BONE DISEASES, COMPRISING TRIPLE AGONIST OR CONJUGATE THEREOF HAVING ACTIVITY WITH RESPECT TO ALL OF GLUCAGON, GLP-1 AND GLP RECEPTORS

HANMI PHARM CO LTD

Query Match 87.0%Identity 89.7%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         |  ||||||||||| ||||||||||||||
Hit    1 HXQGTFTSDVSSYLDGQAAKEFIAWLVKG 29
```
26 of 29 identical, no gaps.
JP 2023543043-A2023-10-12

THERAPEUTIC USE OF LONG-ACTING CONJUGATE OF TRIPLE AGONIST ACTING ON ALL OF GLUCAGON, GLP-1 AND GIP RECEPTORS AGAINST MULTIPLE SCLEROSIS

HANMI PHARM CO LTD

Query Match 87.0%Identity 89.7%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         |  ||||||||||| ||||||||||||||
Hit    1 HXQGTFTSDVSSYLDGQAAKEFIAWLVKG 29
```
26 of 29 identical, no gaps.
JP 2023546384-A2023-11-02

USE OF TRIGONAL AGONIST HAVING ACTIVITIES TO ALL OF GLUCAGON, GLP-1, AND GIP RECEPTORS IN TREATMENT OF SEQUELAE FOLLOWING RESPIRATORY INFECTIOUS DISEASES

HANMI PHARM CO LTD

Query Match 87.0%Identity 89.7%Family of 2
Best alignment and family
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         |  ||||||||||| ||||||||||||||
Hit    1 HXQGTFTSDVSSYLDGQAAKEFIAWLVKG 29
```
26 of 29 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- JP 2023546384-A2023-11-02
- JP 2026091850-A2026-06-04
EP 4311578-A22024-01-31

TRIPLE AGONIST HAVING ACTIVITY WITH RESPECT TO ALL OF GLUCAGON, GLP-1, AND GIP RECEPTORS FOR TREATING LIVER DISEASE

HANMI PHARM IND CO LTD

Query Match 87.0%Identity 89.7%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         |  ||||||||||| ||||||||||||||
Hit    1 HXQGTFTSDVSSYLDGQAAKEFIAWLVKG 29
```
26 of 29 identical, no gaps.
JP 2024527220-A2024-07-24

THERAPEUTIC USE OF COMBINATION INCLUDING TRIPLE AGONIST HAVING ACTIVITIES TO ALL OF GLUCAGON, GLP-1, AND GIP RECEPTORS

HANMI PHARM CO LTD

Query Match 87.0%Identity 89.7%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         |  ||||||||||| ||||||||||||||
Hit    1 HXQGTFTSDVSSYLDGQAAKEFIAWLVKG 29
```
26 of 29 identical, no gaps.
EP 4454658-A12024-10-30

LIVER-TARGETED SUBSTANCE AND USE THEREOF

HANMI PHARMACEUTICAL CO LTD

Query Match 87.0%Identity 89.7%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         |  ||||||||||| ||||||||||||||
Hit    1 HXQGTFTSDVSSYLDGQAAKEFIAWLVKG 29
```
26 of 29 identical, no gaps.
JP 2025502749-A2025-01-28

LIVER-TARGETED DRUG AND USE THEREOF

HANMI PHARM. CO., LTD

Query Match 87.0%Identity 89.7%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         |  ||||||||||| ||||||||||||||
Hit    1 HXQGTFTSDVSSYLDGQAAKEFIAWLVKG 29
```
26 of 29 identical, no gaps.
JP 2025085685-A2025-06-05

Patent application sequence for JP 2025085685-A/100

HANMI PHARM. CO., LTD

Query Match 87.0%Identity 89.7%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         |  ||||||||||| ||||||||||||||
Hit    1 HXQGTFTSDVSSYLDGQAAKEFIAWLVKG 29
```
26 of 29 identical, no gaps.
KR 1020150008012-A2015-01-21

Conjugate of biologically active polypeptide monomer and immunoglobulin Fc fragment with reduced receptor-mediated clearance, and the method for preparing the same

HANMI PHARM. CO., LTD

Query Match 85.7%Identity 93.1%Family of 5
Best alignment and family
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         | ||||||||||||| |||||||||||||
Hit    1 HGEGTFTSDVSSYLEEQAAKEFIAWLVKG 29
```
27 of 29 identical, no gaps.
Family of 5
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020150008012-A2015-01-21
- JP 2016529227-A2016-09-23
- US 10487128-B22019-11-26
- KR 1020200136856-A2020-12-08
- JP 2021059585-A2021-04-15
KR 1020200117881-A2020-10-14

METHOD OF EXPRESSING AND PURIFYING PROTEIN USING CSQ-TAG

Korea Institute of Ceramic Engineering and Technology

Query Match 85.7%Identity 93.1%
Best alignment
Query 1 to 29, hit 3 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         | ||||||||||||| |||||||||||||
Hit    3 HGEGTFTSDVSSYLEEQAAKEFIAWLVKG 31
```
27 of 29 identical, no gaps.
JP 2021531259-A2021-11-18

MODULATORS OF G-PROTEIN COUPLED RECEPTORS

CARMOT THERAPEUTICS INC

Query Match 85.7%Identity 100.0%Family of 2
Best alignment and family
Query 3 to 29, hit 1 to 27. Positions start at 1 and include both ends.
```
Query  3 EGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         |||||||||||||||||||||||||||
Hit    1 EGTFTSDVSSYLEGQAAKEFIAWLVKG 27
```
27 of 27 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- JP 2021531259-A2021-11-18
- JP 2024156720-A2024-11-06
JP 2022528132-A2022-06-08

METHOD FOR EXPRESSING AND PURIFYING PROTEIN BY USING CSQ-TAG

KOREA INSTITUTE OF CERAMIC ENGINEERING AND TECHNOLOGY

Query Match 85.7%Identity 93.1%
Best alignment
Query 1 to 29, hit 3 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         | ||||||||||||| |||||||||||||
Hit    3 HGEGTFTSDVSSYLEEQAAKEFIAWLVKG 31
```
27 of 29 identical, no gaps.
US 11535660-B12022-12-27

Modulators of G-protein coupled receptors

Cannot Therapeutics, Inc.

Query Match 85.7%Identity 100.0%
Best alignment
Query 3 to 29, hit 1 to 27. Positions start at 1 and include both ends.
```
Query  3 EGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         |||||||||||||||||||||||||||
Hit    1 EGTFTSDVSSYLEGQAAKEFIAWLVKG 27
```
27 of 27 identical, no gaps.
KR 1020230126655-A2023-08-30

Metal ions-reactive particles based on calciquestrin and uses thereof

ToolBio. Co.,Ltd

Query Match 85.7%Identity 93.1%
Best alignment
Query 1 to 29, hit 3 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         | ||||||||||||| |||||||||||||
Hit    3 HGEGTFTSDVSSYLEEQAAKEFIAWLVKG 31
```
27 of 29 identical, no gaps.
WO 2025163186-A12025-08-07

CONJUGATED NUCLEIC ACIDS AND NUCLEIC ACIDS COMPRISING LOCKED NUCLEOSIDES AND INVERTED NUCLEOTIDES FOR INHIBITING GENE EXPRESSION IN A CELL

SILENCE THERAPEUTICS GMBH

Query Match 85.7%Identity 93.1%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         | ||||||||||||| |||||||||||||
Hit    1 HXEGTFTSDVSSYLEEQAAKEFIAWLVKG 29
```
27 of 29 identical, no gaps.
WO 2025172605-A12025-08-21

COMPOSITION COMPRISING A PEPTIDE HAVING AN ISOELECTRIC POINT OF LESS THAN 6.5 AND A CO-POLYAMINO ACID BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS

ADOCIA

Query Match 85.7%Identity 83.9%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||| ||| ||| ||| |||
Hit    1 HVEGTFTSDVSSYLEEQAAREFIKWLVRGRG 31
```
26 of 31 identical, no gaps.
KR 1020250168625-A2025-12-02

CALCITONIN ANALOGUE, AND DERIVATIVE THEREOF AND USE THEREOF

HANGZHOU SCIWIND BIOSCIENCES CO., LTD.

Query Match 85.7%Identity 83.9%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||||||||| ||| ||| ||| |||
Hit    1 HVEGTFTSDVSSYLEEQAAREFIKWLVRGRG 31
```
26 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020250168625-A2025-12-02
- EP 4692114-A12026-02-11
US 5981488-A1999-11-09

Glucagon-like peptide-1 analogs

Query Match 85.1%Identity 93.1%
Best alignment
Query 3 to 31, hit 3 to 31. Positions start at 1 and include both ends.
```
Query  3 EGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||| ||||| ||||||||||
Hit    3 EGTFTSDVSSYLXGQAAKXFIAWLVKGRG 31
```
27 of 29 identical, no gaps.
US 9186392-B22015-11-17

Combination therapy

Boehringer Ingelheim International GmbH

Query Match 85.1%Identity 89.7%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         | ||||||||||||| |||||||||| ||
Hit    1 HVEGTFTSDVSSYLEEQAAKEFIAWLIKG 29
```
26 of 29 identical, no gaps.
US 9526730-B22016-12-27

Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome

Boehringer Ingelheim International GmbH

Query Match 85.1%Identity 89.7%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         | ||||||||||||| |||||||||| ||
Hit    1 HVEGTFTSDVSSYLEEQAAKEFIAWLIKG 29
```
26 of 29 identical, no gaps.
US 9603851-B22017-03-28

Combination therapy

Boehringer Ingelheim International GmbH

Query Match 85.1%Identity 89.7%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         | ||||||||||||| |||||||||| ||
Hit    1 HVEGTFTSDVSSYLEEQAAKEFIAWLIKG 29
```
26 of 29 identical, no gaps.
US 10004747-B22018-06-26

Combination therapy

Boehringer Ingelheim International GmbH

Query Match 85.1%Identity 89.7%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         | ||||||||||||| |||||||||| ||
Hit    1 HVEGTFTSDVSSYLEEQAAKEFIAWLIKG 29
```
26 of 29 identical, no gaps.
US 10195203-B22019-02-05

Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome

Boehringr Ingelheim International GmbH

Query Match 85.1%Identity 89.7%
Best alignment
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         | ||||||||||||| |||||||||| ||
Hit    1 HVEGTFTSDVSSYLEEQAAKEFIAWLIKG 29
```
26 of 29 identical, no gaps.
KR 1020250099250-A2025-07-01

METHODS FOR TREATING OBESITY

AMGEN Inc

Query Match 85.1%Identity 87.1%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||| ||||| ||||||||||||| |
Hit    1 HXEGTFTSDYSSYLEEQAAKEFIAWLVKGGG 31
```
27 of 31 identical, no gaps.
WO 2026013265-A12026-01-15

NOVEL DIPEPTIDE ACYLATING AGENTS

NOVO NORDISK AS

Query Match 85.1%Identity 86.7%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         | ||||||||||||| ||| ||||||| ||
Hit    1 HXEGTFTSDVSSYLEEQAAREFIAWLVRGR 30
```
26 of 30 identical, no gaps.
WO 2026147836-A12026-07-09

CONVERGENT PEPTIDE SYNTHESIS METHODS

AMGEN INC

Query Match 85.1%Identity 87.1%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | ||||||| ||||| ||||||||||||| |
Hit    1 HXEGTFTSDYSSYLEEQAAKEFIAWLVKGGG 31
```
27 of 31 identical, no gaps.
WO 2007100535-A2007-09-07

Oxyntomodulin derivatives

ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT)

Query Match 84.5%Identity 96.3%
Best alignment
Query 1 to 27, hit 1 to 27. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLV 27
         ||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLM 27
```
26 of 27 identical, no gaps.
JP 2009527558-A2009-07-30

Oxyntomodulin Derivatives

Merck and Co Inc

Query Match 84.5%Identity 96.3%
Best alignment
Query 1 to 27, hit 1 to 27. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLV 27
         ||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLM 27
```
26 of 27 identical, no gaps.
US 7928058-B22011-04-19

Pharmaceutical composition comprising oxyntomodulin derivatives and a method for reducing body weight using the composition

Merck Sharp & Dohme Corp. and Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.p.A.

Query Match 84.5%Identity 96.3%
Best alignment
Query 1 to 27, hit 1 to 27. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLV 27
         ||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLM 27
```
26 of 27 identical, no gaps.
EP 2471810-A12012-07-04

Oxyntomodulin derivatives

MERCK SHARP & DOHME

Query Match 84.5%Identity 96.3%Family of 2
Best alignment and family
Query 1 to 27, hit 1 to 27. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLV 27
         ||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLM 27
```
26 of 27 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- EP 2471810-A12012-07-04
- EP 2471811-A12012-07-04
US 8268779-B22012-09-18

Pharmaceutical composition comprising oxyntomodulin derivatives and a method for reducing body weight using the composition

Merck Sharp & Dohme Corp.

Query Match 84.5%Identity 96.3%
Best alignment
Query 1 to 27, hit 1 to 27. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLV 27
         ||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLM 27
```
26 of 27 identical, no gaps.
EP 4642484-A12025-11-05

TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE

HANGZHOU SEEHE BIOTECHNOLOGY CO LTD

Query Match 84.5%Identity 80.6%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         || |||||||||   ||||| |||||| |||
Hit    1 HAQGTFTSDVSSLYQGQAAKQFIAWLVRGRG 31
```
25 of 31 identical, no gaps.
Family of 2
Grouped by a shared priority claim, WO2023CN96066.
- EP 4642484-A12025-11-05
- EP 4642492-A12025-11-05
WO 2006124529-A12006-11-23

Glp-1 pegylated compounds

Eli Lilly and Company (US)

Query Match 83.2%Identity 89.7%Family of 4
Best alignment and family
Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
         | ||||||||||||| |||||||||| ||
Hit    1 HXEGTFTSDVSSYLEXQAAKEFIAWLXKG 29
```
26 of 29 identical, no gaps.
Family of 4
Grouped by the same title and applicant. No priority claim is on record.
- WO 2006124529-A12006-11-23
- JP 2008540565-A2008-11-20
- US 8183340-B22012-05-22
- JP 2013079256-A2013-05-02
WO 2010054007-A12010-05-14

Combinatorial antibody libraries and uses thereof

Fabrus Llc (US)

Query Match 83.2%Identity 93.3%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         |||||||||||||||||  |||||||||||
Hit    1 HAEGTFTSDVSSYLEGQM-KEFIAWLVKGR 29
```
28 of 30 identical, 1 gap.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- WO 2010054007-A12010-05-14
- US 9221902-B22015-12-29
JP 2012508016-A2012-04-05

COMBINATORIAL ANTIBODY LIBRARIES AND USES THEREOF

Fabrus LLC,Vaughn Smider,James Graziano,Helen Hongyuan Mao,Byeong Doo Song, Tyson Chase,Omar Bazirgan

Query Match 83.2%Identity 93.3%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         |||||||||||||||||  |||||||||||
Hit    1 HAEGTFTSDVSSYLEGQM-KEFIAWLVKGR 29
```
28 of 30 identical, 1 gap.
Family of 2
Grouped by a shared priority claim, US 61/198764.
- JP 2012508016-A2012-04-05
- JP 2016127850-A2016-07-14
US 10774138-B22020-09-15

Combinatorial antibody libraries and uses thereof

Taurus Biosciences, LLC

Query Match 83.2%Identity 93.3%
Best alignment
Query 1 to 30, hit 1 to 29. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         |||||||||||||||||  |||||||||||
Hit    1 HAEGTFTSDVSSYLEGQM-KEFIAWLVKGR 29
```
28 of 30 identical, 1 gap.

GLP-1, a diabetes hormone

The search

Patents

Family of 2

Family of 2

Family of 2

Family of 2

Family of 2

Family of 5

Family of 2

Family of 2

Family of 2

Family of 2

Family of 4

Family of 2

Family of 2